Odyssey Health (ODYY) Net Cash Flow Growth (1y) (2015 - 2026)
Odyssey Health (ODYY) Net Cash Flow Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -562.77% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 2,827.78% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | -395.56% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 168.38% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | -103.49% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -114.85% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -215.59% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -54.17% |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - | -7,861.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -7,861.03% |
| Jan 31, 2026 | 1,365.57% |
| Oct 31, 2025 | -87.37% |
| Jul 31, 2025 | 124.98% |
| Apr 30, 2025 | 96.00% |
| Jan 31, 2025 | -47.05% |
| Oct 31, 2024 | -68.02% |
| Jul 31, 2024 | -278.59% |
| Apr 30, 2024 | -189.73% |
| Jan 31, 2024 | -115.83% |
| Oct 31, 2023 | 830.73% |
| Jul 31, 2023 | -83.76% |
| Apr 30, 2023 | -125.61% |
| Jan 31, 2023 | 95.67% |
| Oct 31, 2022 | 74.21% |
| Jul 31, 2022 | 112.51% |
| Apr 30, 2022 | -89.74% |
| Jan 31, 2022 | -47.94% |
| Oct 31, 2021 | -137.18% |
| Jul 31, 2021 | -4,930.91% |